Cefdinir
- Product NDC
- 67877-524
- Requested package NDC
- 67877-524-01
- 11-digit product format
- 678770524
- Labeler code
- 67877
- Product ID
- 67877-524_ed161b31-baa3-458b-a83b-fe301ad5c455
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefdinir
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Ascend Laboratories, LLC
- Application
- ANDA210220
- Marketing category
- ANDA
- Marketing start
- 2021-02-20
- Marketing end
- 0000-00-00
- Substance
- CEFDINIR
- Active strength
- 300 mg/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 67877-524 | 67877-524-01 | D | Discontinued by firm | 2026-08-03 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210220-001 | CEFDINIR | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A210220-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 87673890dc5c… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210220-001 | CEFDINIR | 300MG | CAPSULE / ORAL | AB | 2021-02-19 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A210220-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210220-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A210220-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210220-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210220-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210220-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210220-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210220-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210220-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A210220-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210220-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210220-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210220-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A210220-001 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210220-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A210220-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A210220-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | A210220-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A210220-001 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A210220-001 | AB | 1 | 87673890dc5c… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A210220-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A210220-001 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A210220-001 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A210220-001 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A210220-001 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A210220-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A210220-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A210220-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A210220-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A210220-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A210220-001 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A210220-001 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A210220-001 | AB | 1 | cb3db0bc1861… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210220-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefdinir | CEFDINIR | Northwind Health Company, LLC | 1d0d50ba-8c2b-855c-e063-6394a90a5c7d | 2026-07-09 | Warnings, Adverse reactions | 210220 ANDA210220 |
| Cefdinir | CEFDINIR | Proficient Rx LP | 63d2f931-6896-47e5-905e-4f812d6cb105 | 2026-06-01 | Warnings, Adverse reactions | 210220 ANDA210220 |
| Cefdinir | CEFDINIR | REMEDYREPACK INC. | a8029f7c-6353-46db-8c8c-c86a9485a14f | 2026-05-15 | Warnings, Adverse reactions | 210220 ANDA210220 |
| Cefdinir | CEFDINIR | NuCare Pharmaceuticals,Inc. | c23af6af-a97b-b98d-e053-2995a90ae780 | 2026-03-13 | Warnings, Adverse reactions | 210220 ANDA210220 |
| Cefdinir | CEFDINIR | Major Pharmaceuticals | a0934baf-4745-4546-a63a-d4a660a188b3 | 2025-10-23 | Warnings, Adverse reactions | 210220 ANDA210220 |
| Cefdinir | CEFDINIR | Bryant Ranch Prepack | 63aa0304-574f-4d37-9fb4-26ffb058fbec | 2025-08-20 | Warnings, Adverse reactions | 210220 ANDA210220 |
| Cefdinir | CEFDINIR | Bryant Ranch Prepack | d5fd32d8-66de-4a9f-9b83-88b190a90377 | 2025-08-19 | Warnings, Adverse reactions | 210220 ANDA210220 |
| Cefdinir | CEFDINIR | Ascend Laboratories, LLC | 18888955-4db3-4d0d-939f-eaaa5f2e0dc4 | 2025-06-25 | Warnings, Adverse reactions | 210220 ANDA210220 |
| Cefdinir | CEFDINIR | Preferred Pharmaceuticals Inc. | c5142dca-4fb8-467d-910a-e8228e694c94 | 2025-02-17 | Warnings, Adverse reactions | 210220 ANDA210220 |
| Cefdinir | CEFDINIR | Redpharm Drug, Inc. | f3d228c8-bde9-ffcf-e053-2a95a90aa5c4 | 2025-01-23 | Warnings, Adverse reactions | 210220 ANDA210220 |
| CEFDINIR | CEFDINIR | DirectRx | d70b9e1f-908f-b570-e053-2995a90af098 | 2025-01-21 | Warnings, Adverse reactions | 210220 ANDA210220 |
| Cefdinir | CEFDINIR | NuCare Pharmaceuticals,Inc. | c974d975-8616-3551-e053-2995a90a65f3 | 2025-01-14 | Warnings, Adverse reactions | 210220 ANDA210220 |
| Cefdinir | CEFDINIR | American Health Packaging | c493e78b-afa3-4f74-8305-75e5f3817df0 | 2024-06-07 | Warnings, Adverse reactions | 210220 ANDA210220 |
| Cefdinir | CEFDINIR | A-S Medication Solutions | 10bf69e7-5f7e-4448-9f22-777f137d9666 | 2023-12-25 | Warnings, Adverse reactions | 210220 ANDA210220 |
| Cefdinir | CEFDINIR | A-S Medication Solutions | a217d454-4ca0-4b29-8a64-eb9393a85269 | 2023-11-21 | Warnings, Adverse reactions | 210220 ANDA210220 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 67877-524-01 | 67877052401 | 100 CAPSULE in 1 BOTTLE (67877-524-01) | 100 capsule | 2021-02-20 | 0000-00-00 | No | No | Current |